Skip to main navigation Skip to search Skip to main content

Childhood cerebellar hemangioblastoma does not predict germline or somatic mutations in the von Hippel-Lindau tumor suppressor gene

  • Paul Graham Fisher
  • , Art Tontiplaphol
  • , Eric M. Pearlman
  • , Patricia K. Duffner
  • , Douglas J. Hyder
  • , Catherine A. Stolle
  • , Alexander O. Vortmeyer
  • , Zhengping Zhuang
  • Stanford University
  • Johns Hopkins University
  • University of Southern California
  • University of Pennsylvania
  • National Institutes of Health

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Tumor suppressor gene "knockout" models would predict that children who present with hemangioblastoma are likely to harbor germline mutation of the von Hippel-Lindau gene. We screened 6 pediatric patients with cerebellar hemangioblastoma for germline or somatic mutations of the von Hippel-Landau gene. Two had prior clinical manifestations of von Hippel-Lindau disease and, as expected, had germline von Hippel-Lindau gene mutations. Four children with solitary hemangioblastoma did not have a detectable germline deletion, rearrangement, or point mutation in their von Hippel-Landau gene, and tumor specimens in 3 of these 4 showed no somatic von Hippel-Landau allelic loss. Solitary cerebellar hemangioblastoma in children does not predict a germline or somatic mutation in the von Hippel-Landau tumor suppressor gene. The tumorigenesis of hemangioblastoma in younger patients may differ from that in adults, and may involve a molecular process unrelated to the von Hippel Lindau tumor suppressor pathway.

Original languageEnglish
Pages (from-to)257-260
Number of pages4
JournalAnnals of Neurology
Volume51
Issue number2
DOIs
StatePublished - 2002

Fingerprint

Dive into the research topics of 'Childhood cerebellar hemangioblastoma does not predict germline or somatic mutations in the von Hippel-Lindau tumor suppressor gene'. Together they form a unique fingerprint.

Cite this